CS-5008

N/A

Report date: 2025/06/05 10:15:51

Base Information

Drug NameCS-5008
Drug Alias NameCS5008CS-5008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Somatostatin receptor 2 sensitizersAnti-Delta-like protein 3
TargetsSomatostatin receptor 2Delta-like protein 3
Therapy Area/IndicationsSmall Cell Lung CarcinomaCarcinoma, NeuroendocrineNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCstone Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCstone Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaCarcinoma, NeuroendocrineNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A